Skip to main content
TipRanks
Go Ultimate75% OFF

Lincoln Pharmaceuticals Ltd (LINCOLN) Ratios

1 Followers

Lincoln Pharmaceuticals Ltd Ratios

IN:LINCOLN's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:LINCOLN's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 26Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio5.254.714.845.093.90
Quick Ratio4.533.974.014.123.10
Cash Ratio0.190.130.060.070.08
Solvency Ratio0.770.760.970.970.76
Operating Cash Flow Ratio0.960.880.690.540.84
Short-Term Operating Cash Flow Coverage24.180.0059.2619.6637.25
Net Current Asset Value₹ 4.50B₹ 3.75B₹ 3.39B₹ 2.82B₹ 2.51B
Leverage Ratios
Debt-to-Assets Ratio0.000.000.000.000.00
Debt-to-Equity Ratio0.010.000.000.000.00
Debt-to-Capital Ratio0.010.000.000.000.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.181.191.181.171.23
Debt Service Coverage Ratio19.0351.5941.6320.8822.57
Interest Coverage Ratio82.1247.0556.8138.42113.69
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share2.710.941.262.011.74
Net Debt to EBITDA-0.13-0.11-0.03-0.03-0.05
Profitability Margins
Gross Profit Margin32.81%53.26%51.24%51.33%52.60%
EBIT Margin17.38%17.82%21.22%20.22%20.80%
EBITDA Margin19.54%19.89%23.14%22.12%22.53%
Operating Profit Margin12.40%14.22%14.33%15.45%35.24%
Pretax Profit Margin17.23%17.52%21.06%19.90%20.49%
Net Profit Margin13.10%13.21%16.07%14.44%14.81%
Continuous Operations Profit Margin13.10%13.21%16.07%14.44%14.81%
Net Income Per EBT76.02%75.42%76.33%72.55%72.29%
EBT Per EBIT139.00%123.25%146.89%128.83%58.15%
Return on Assets (ROA)9.87%10.33%13.32%12.41%12.98%
Return on Equity (ROE)11.60%12.26%15.74%14.51%16.02%
Return on Capital Employed (ROCE)10.67%12.83%13.69%15.14%37.17%
Return on Invested Capital (ROIC)8.07%9.67%10.43%10.94%26.75%
Return on Tangible Assets9.88%10.34%13.33%12.42%12.99%
Earnings Yield7.77%7.44%7.79%10.73%11.15%
Efficiency Ratios
Receivables Turnover2.773.092.833.113.09
Payables Turnover5.313.433.914.804.36
Inventory Turnover5.633.703.673.513.05
Fixed Asset Turnover3.443.353.183.193.11
Asset Turnover0.750.780.830.860.88
Working Capital Turnover Ratio1.551.671.791.811.89
Cash Conversion Cycle127.97110.27135.27145.48153.95
Days of Sales Outstanding131.82118.12129.18117.45117.97
Days of Inventory Outstanding64.8598.5899.50104.01119.64
Days of Payables Outstanding68.70106.4393.4075.9883.66
Operating Cycle196.68216.70228.68221.46237.61
Cash Flow Ratios
Operating Cash Flow Per Share53.3946.4431.5619.6038.01
Free Cash Flow Per Share40.6936.8311.8512.4715.28
Dividend Paid and CapEx Coverage Ratio3.684.071.492.271.57
Capital Expenditure Coverage Ratio4.214.831.602.751.67
Operating Cash Flow Coverage Ratio24.180.0059.2619.6637.25
Operating Cash Flow to Sales Ratio0.160.150.110.080.16
Free Cash Flow Yield7.20%6.67%1.98%3.68%4.92%
Valuation Ratios
Price-to-Earnings (P/E) Ratio12.8713.4312.849.328.97
Price-to-Sales (P/S) Ratio1.691.772.061.351.33
Price-to-Book (P/B) Ratio1.491.652.021.351.44
Price-to-Free Cash Flow (P/FCF) Ratio13.8814.9950.4527.2020.33
Price-to-Operating Cash Flow Ratio10.5811.8918.9517.318.17
Price-to-Earnings Growth (PEG) Ratio1.91-1.140.461.820.79
Enterprise Value Multiple8.508.818.886.065.85
Enterprise Value11.14B10.93B11.93B6.76B6.17B
EV to EBITDA8.508.818.886.065.85
EV to Sales1.661.752.061.341.32
EV to Free Cash Flow13.6714.8150.2527.0820.17
EV to Operating Cash Flow10.4211.7518.8717.238.11
Tangible Book Value Per Share377.79335.10295.79250.72215.93
Shareholders’ Equity Per Share378.25335.31295.96250.86216.12
Tax and Other Ratios
Effective Tax Rate0.240.250.240.270.28
Revenue Per Share335.01311.13289.82252.10233.75
Net Income Per Share43.8841.1146.5836.4034.63
Tax Burden0.760.750.760.730.72
Interest Burden0.990.980.990.980.99
Research & Development to Revenue0.000.020.000.000.00
SG&A to Revenue0.200.180.180.040.04
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality1.220.850.680.390.79

Currency in INR